A Phase II Trial of Gallium Nitrate in Patients with Androgen-Metastatic Prostate Cancer

Publisher： Karger

E-ISSN： 1423-0399|63|2|120-125

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.63, Iss.2, 1999-12, pp. : 120-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration‐resistant prostate cancer

By  

BJU INTERNATIONAL, Vol. 118, Iss. 4, 2016-10 ,pp. : 590-597

John Wiley & Sons Inc

Access to resources Recommend Favorite

An Open-Label, Noncomparative Phase II Trial to Evaluate the Efficacy and Safety of Docetaxel in Combination with Gefitinib in Patients with Hormone-Refractory Metastatic Prostate Cancer

By  

Oncology Research and Treatment, Vol. 30, Iss. 7, 2007-06 ,pp. : 355-360

Karger

Access to resources Recommend Favorite

Phase II Clinical Trial of Titanocene Dichloride in Patients with Metastatic Breast Cancer

By  

Oncology Research and Treatment, Vol. 23, Iss. 1, 2000-03 ,pp. : 60-62

Karger

Access to resources Recommend Favorite

The Role of an Androgen Receptor Polymorphism in the Clinical Outcome of Patients with Metastatic Prostate Cancer

By  

Urologia Internationalis, Vol. 68, Iss. 1, 2002-01 ,pp. : 16-23

Karger

Access to resources Recommend Favorite

Gemcitabine as First-Line Therapy in Patients with Metastatic Breast Cancer: A Phase II Trial

By  

Oncology, Vol. 62, Iss. 1, 2002-01 ,pp. : 2-8

Karger

Access to resources Recommend Favorite